Partners and Investors


Plex Pharmaceuticals, Inc., is a privately held early stage pharmaceutical company focused on the rapid discovery of drug-like small molecules for underserved needs including CNS/Systemic oncology, degenerative CNS disorders, and infectious diseases.

While the majority of funding has been attained through non-dilutive mechanisms, we are actively seeking corporate partnership and private investment to advance our programs toward an ultimate goal of investigational new drug (IND) filing.

Plex has successfully secured private funding from investors that include: